Fourpath Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-58
Closed -$2.73K 353
2024
Q3
$2.73K Buy
+58
New +$2.73K ﹤0.01% 626